Opinion of the Scientific Panel on biological hazards (BIOHAZ) on on the assessment of the likelihood of the infectivity in SRM derived from cattle at different age groups estimated by back calculation modelling

EFSA Journal

Volumn 5, Issue 5, 2007, Pages

[No Author Info available]

Author keywords

BSE; Specified Risk Material (SRM)

Indexed keywords

EID: 85078391114     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2007.476     Document Type: Article

References (36)

1. Sc)-accumulating cells in lymphoid and neural tissues of naturally scrapie-affected sheep by double-labeling immunohistochemistry. J Histochem Cytochem 50(10): 1357–70.
2. Andreoletti, O., S. Simon, et al. (2004) PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat Med 10(6): 591–593.
3. Arnold, M.E. & Wilesmith, J.W. (2003) Modelling studies on BSE occurrence to assist in the review of the over 30 months rule in GB. Proc R Soc B (London) 270, 2141–2145.
4. Arnold, M.E. & Wilesmith, J.W. (2004) Estimation of the age-dependent risk of infection to BSE of dairy cattle in Great Britain. Prev Vet Med 66, 35–47.
5. Sc detection and incubation period in experimental bovine spongiform encephalopathy (BSE) of cattle.
6. Buschmann, A. & Groschup, M. H. (2005) Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis 192, 934–942.
7. Castilla, J., P. Saa, et al. (2005) Detection of prions in blood. Nat Med 11(9): 982–5.
8. Erdtmann, R., and Sivitz, L. B. (2003) Advancing Prion Science. Guidance for the National Prion Research Program, pp. 288, The National Academies Press, Washington, DC.
9. Espinosa, J.C., Morales, M., Castilla, J., Rogers, M. and Torres, J. Ml. (2007) Progression of prion infectivity in asympomatic cattle after oral bovine spongiform encephalopathy challenge. J Gen Virol., 88, 1379–1383.
10. European Commission (2002) SSC Of 8 November 2002. Update Of The Opinion On TSE Infectivity Distribution In Ruminant Tissues. Initially adopted by The Scientific Steering Committee at its Meeting of 10–11 January 2002 and amended at its Meeting of 7–8 November 2002, following the submission of (1) A Risk Assessment by the German Federal Ministry of Consumer Protection, Food and Agriculture and (2) New scientific evidence regarding BSE infectivity distribution in tonsils. europa.eu.int./comm/food/fs/sc/ssc/outcome_en.html
11. European Food Safety Authority (2005a) Opinion of the BIOHAZ Panel on classification of atypical Transmissible Spongiform Encephalopathy (TSE) cases in Small Ruminants. The EFSA Journal 276: 1–30.
12. European Food Safety Authority (2005b) Quantitative assessment of the residual BSE risk in bovine-derived products- EFSA, QRA Report 2004. The EFSA Journal (2005) 307, 1–135
13. European Food Safety Authority (2005c) Annex to the Opinion. Report of the Working Group on the assessment of the age limit in cattle for the removal of certain specified risk materials (SRM). Annex to the opinion of the Scientific Panel on Biological Hazards on the assessment of the age limit in cattle for the removal of certain Specified Risk Materials (SRM). The EFSA Journal (2005) 220, 1–21.
14. Ferguson, N.M. & Donnelly, C.A. (2003) Assessment of risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of changes to current control measures. Proc R Soc B (London) 270, 1579–1584.
15. Fraser, H. & Foster, J. (1994) Transmission to mice, sheep and goats and bioassay of bovine tissues. In Transmissible Spongiform Encephalopathies. A Consultation on BSE with the Scientific Veterinary Committee of the Commission of the European Communities held in Brussels, September 14–15 1993, pp 145–159 Edited by R. Bradley & B. Marchant. Document VI/4131/94-EN. Brussels, European Commission Agriculture.
16. Gatti, J. L., S. Metayer, et al. (2002) Prion protein is secreted in soluble forms in the epididymal fluid and proteolytically processed and transported in seminal plasma. Biol Reprod 67(2): 393–400.
17. Grassi, J., Comoy, E., Simon, S., Créminon, C., Frobert, Y., Trapmann, S., Schimmel, H., Hawkins, S.A.C., Moynagh, J., Deslys, J.P. & Wells, G.A.H. (2001) Preclinical postmortem diagnosis of BSE in central nervous system tissue using a rapid test. Vet. Rec.149: 577–582.
18. Hoffmann, C., U. Ziegler, et al. (2007) Prions spread via the autonomic nervous system from the gut to the central nervous system in cattle incubating bovine spongiform encephalopathy. J Gen Virol 88(Pt 3): 1048–55.
19. Juling, K., Schwarzenbacher, H., Williams, J.L. & Fries, R. (2006) A major genetic component of BSE susceptibility. BMC Biol 4, 33–41.
20. Le Dur, A., Beringue, V., Andreoletti, O., Reine, F., Lai, TL., Baron, T., Bratberg, B., Vilotte, J.L., Sarradin, P., Benestad, S.L. and Laude, H. (2005) A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A, 102(44):16031–6. Epub.
21. McBride P.A., Schulz-Schaeffer W.J., Donaldson M., Bruce M., Diringer H., Kretzschmar H.A., and Beekes M. (2001) Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J. Virol. 75: 9320–9327.
22. McKinley, M. P., D. C. Bolton, et al. (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35(1): 57–62.
23. Moudjou, M., Frobert, Y., Grassi, J. and La Bonnardiere, C. (2001) Cellular prion protein status in sheep: tissue-specific biochemical signatures. Journal of General Virology, 82, 2017–2024.
24. Polak, M.P. and Zmudzinski, J.F. (2005) Bovine spongiform encephalopathy in Poland. Vet Rec. 157(2), 56–58.
25. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216(4542): 136–44.
26. Race, E. (2001) Cross-resistance within the protease inhibitor class. Antivir Ther 6 Suppl 2: 29–36.
27. Sander, P., H. Hamann, et al. (2004) Analysis of sequence variability of the bovine prion protein gene (PRNP) in German cattle breeds. Neurogenetics 5(1): 19–25.
28. SEAC (2006) Annual Report of the Spongiform Encephalopathy Advisory Committee. www.seac.gov.uk/publicats/annualreport2006.pdf
29. Terry, L.A., Marsh, S., Ryder, S.J., Hawkins, S.A.C., Wells, G.A.H. & Spencer, Y.I. (2003) Detection of disease-specific PrP in the distal ileum of cattle orally exposed to the BSE agent. Vet Rec 152, 387–392.
30. Thackray, A. M., M. A. Klein, et al. (2003) Subclinical prion disease induced by oral inoculation. J Virol 77(14): 7991–8.
31. Wells, G.A.H., Dawson, M., Hawkins, S.A.C., Austin, A.R., Green, R.B., Dexter, I., Horigan, M.W. & Simmons, M.M. (1996) Preliminary observations of experimental bovine spongiform encephalopathy. In Bovine Spongiform Encephalopathy- The BSE dilemma, pp. 28–44. Edited by C.J. Gibbs Jr. New York: Springer.
32. Wells, G. A., S. A. Hawkins, et al. (1998) Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 142(5): 103–6.
33. Wells, G. A., J. Spiropoulos, et al. (2005) Pathogenesis of experimental bovine spongiform encephalopathy: preclinical infectivity in tonsil and observations on the distribution of lingual tonsil in slaughtered cattle. Vet Rec 156(13): 401–7.
34. Wells, G. A., T. Konold, et al. (2007) Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J Gen Virol 88(Pt 4): 1363–73.
35. Wilesmith, J.W., Wells, G.A.H., Cranwell, M.P. & Ryan, J.B.M. (1988) Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 123, 638–644.
36. World Health Organization (2006) WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies. www.who.int/bloodproducts/tse/WHO%20TSE%20Guidelines%20FINAL-22%20JuneupdatedNL.pdf